Expert hematologist/oncologist Paul Szabolcs, MD, reviews positive data from a clinical trial comparing hematopoietic stem cell transplantation and omidubicel with standard cord blood transplantation.
Rapid Readouts
Advertisement
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
3
Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
4
Janna Minehart, MD, on Hematology-Oncology Immunotherapy Highlights at ASH 2025
5
